How Opvee went bust

Approved by the FDA in 2023, Opvee, a nasal spray version of nalmefene developed by Indivior for reversing opioid overdoses and more powerful than Narcan, was more expensive and was claimed to have significant withdrawal risks. Stat Pharmalot looked at how the harm reduction community worked to get the drug withdrawn.